|
⚲
|
| Keyboard |
| Cain Daniel F
✚
|
|
|---|---|
| CIK # | 0001274244 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 4 | [0001274244] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Repros Therapeutics Inc | |
| Cain Daniel F |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Repros Therapeutics Inc RPRX
Common Stock
|
2018-01-31 | Disposed to issuer | 27,779 | $0.67 | 18,612 |
|
Repros Therapeutics Inc RPRX
Stock Option · derivative
|
2018-01-31 | Disposed to issuer | 5,000 | ||
|
Repros Therapeutics Inc RPRX
Common Stock
|
2018-01-29 | Tender | 23,221 | $0.67 | 15,558 |
|
Repros Therapeutics Inc RPRX
Stock Option · derivative
|
2017-09-15 | Grant | 5,000 | ||
|
Repros Therapeutics Inc RPRX
Common Stock
|
2017-02-13 | Grant | 40,000 | ||
|
Repros Therapeutics Inc RPRX
Stock Option · derivative
|
2016-06-30 | Grant | 5,000 | ||
|
Repros Therapeutics Inc RPRX
Stock Option · derivative
|
2015-05-28 | Grant | 5,000 | ||
|
Repros Therapeutics Inc RPRX
Stock Option (right to buy Common Stock) · derivative
|
2015-02-05 | Grant | 30,000 | ||
|
Repros Therapeutics Inc RPRX
Stock Option · derivative
|
2014-06-16 | Grant | 5,000 | ||
|
Repros Therapeutics Inc RPRX
Common Stock
|
2014-01-10 | Option exercise | 10,000 | $9.60 | 96,000 |
|
Repros Therapeutics Inc RPRX
Stock Option (right to buy) · derivative
|
2014-01-10 | Option exercise | 10,000 | ||
|
Repros Therapeutics Inc RPRX
Common Stock
|
2013-11-12 | Buy | 500 | $14.97 | 7,485 |
|
Repros Therapeutics Inc RPRX
Stock Option · derivative
|
2013-06-18 | Grant | 5,000 | $0.00 | |
|
Repros Therapeutics Inc RPRX
Stock Option · derivative
|
2012-06-13 | Grant | 5,000 | $0.00 |